RE:RE:RE:RE:RE:RE:RE:RE:RE:Update?so far your plan has been dilute shares, increase debt, and throw hail mary passes. One potentially good thing is the development of the SAAS version however since it was announced in sept of 2018 and still no takers, I'm beginning to wonder.
There have been a number of failed partnerships (basically no news after initial anouncement) Now just whispers about Brazil but no hard facts. No news on feedback from Spain. No feedback on Netherlands. No ability to close a deal in Canada or the USA. No apparent acceptance by the Canadian Dermatology community.
So far mainly hot air coming from the offices of MDX